STRATA Skin Sciences (NASDAQ:SSKN) Now Covered by Analysts at Maxim Group

Maxim Group assumed coverage on shares of STRATA Skin Sciences (NASDAQ:SSKN) in a research note issued to investors on Thursday morning,Benzinga reports. The brokerage issued a buy rating and a $6.00 target price on the medical device company’s stock.

STRATA Skin Sciences Stock Performance

SSKN stock opened at $2.64 on Thursday. The stock has a 50-day moving average price of $2.87 and a 200-day moving average price of $2.97. STRATA Skin Sciences has a 1-year low of $2.51 and a 1-year high of $6.00. The company has a current ratio of 1.13, a quick ratio of 0.94 and a debt-to-equity ratio of 1.62. The firm has a market cap of $11.01 million, a PE ratio of -0.99 and a beta of 1.33.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.